SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Threshold is a project merged from the NuCypher and Keep networks, which strives to provide different threshold cryptography solutions in a fully decentralized manner to the web3 community. Threshold cryptography is a technology that uses cryptography to unlock greater utility and usability for digital assets without needing to trust a centralized party. Threshold cryptography distributes sensitive operations across multiple independent entities – like nodes in a network – and requires a threshold, or minimum number of those entities to cooperate for the operation to be successful.

Threshold Network Token

Threshold Network Token ($T) is capturing attention due to its enhanced role in decentralized finance, particularly with its tBTC solution positioned as a secure alternative for bringing Bitcoin on-chain. The community is highly focused on its potential to replace Wrapped Bitcoin (WBTC) and anticipating a significant breakout, fueled by increased visibility and ongoing discussion surrounding its merger with NuCypher and Keep Network. Many view it as a "hidden gem" ready for substantial long-term growth within the crypto ecosystem.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is drawing significant attention amid concerns over a spreading severe flu variant and potential bird flu risks, highlighting its mRNA vaccine candidates. Despite a recent market reaction to mixed interim cystic fibrosis data, many perceive the sell-off as overdone, focusing on positive biological signals like mucus plug reduction for an underserved patient group. The community is actively debating the stock's undervaluation, the impact of a trade secret lawsuit against AbbVie, and the potential for a short squeeze as key drivers.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as it fortifies its pipeline with successful HIV treatment advancements and strategic oncology acquisitions, notably licensing Assembly Bio's herpes programs and acquiring a Repare Therapeutics cancer asset. Despite these gains, community sentiment is nuanced due to a setback in its Trodelvy cancer trial and CVS Health's recent decision regarding coverage for its new HIV prevention treatment, Yeztugo.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly (FSLY) is drawing attention following KeyBanc's upgrade, a planned Nasdaq listing, and recent strong financial results that showcase record profitability and free cash flow. While some investors are optimistic about its edge computing capabilities, AI security products, and potential for a significant TikTok partnership, others remain cautious due to historical volatility and a recent convertible notes offering. Community discussions frequently pit Fastly's future growth against larger competitors like Cloudflare, emphasizing its potential for a turnaround.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is experiencing renewed interest due to surging demand for decentralized data storage from AI and Web3 projects, with recent network upgrades, record-high storage deals, and a strong presence in the DePIN sector driving conversation. The community views $FIL as a crucial, yet undervalued, piece of infrastructure, actively discussing its potential for significant growth as a foundational layer for verifiable and censorship-resistant data.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF ($GDX) is trending as gold and silver surge to new all-time highs, fueled by robust central bank demand and broader geopolitical uncertainties. The community is actively discussing the potential for significant upward moves in miners, believing they are currently undervalued relative to the metals and anticipating a substantial short squeeze. Many foresee GDX entering a "parabolic stage" with further gains as a long-term bull market unfolds.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is a focal point of discussion following a market reaction to recently adjusted guidance and a CFO transition, which prompted a notable price decline and high trading volume. Many investors view this as an overreaction, highlighting the company's robust annual recurring revenue, positive free cash flow, and strong position in the AI-native cybersecurity sector as indicators of undervaluation. This sentiment fuels frequent community speculation about its potential as an acquisition target or a significant rebound in value over the coming years.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Silver (SLV) is experiencing a historic, parabolic rally, primarily fueled by strong industrial demand for green technology and AI, alongside China's impending export restrictions on the metal. This surge has ignited intense debate within the community, with many anticipating a significant short squeeze and a multi-year 'generational run' driven by physical supply shortages. However, others caution that the rally is an unsustainable 'blow-off top,' noting increased COMEX margin requirements as a potential indicator of an impending correction.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is buzzing after securing multiple key FDA approvals for its cancer treatment Libtayo, expanded indications for EYLEA HD, and a pediatric label for Evkeeza, alongside breakthrough gene therapy trial results. This strong pipeline momentum and an earnings beat are fueling a largely bullish community sentiment, with many investors viewing the biopharmaceutical giant as a compelling long-term hold despite some lingering manufacturing-related concerns.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is experiencing significant bullish momentum, driven by its recent Zebra 3.1.0 network upgrade, institutional interest highlighted by Cypherpunk's increased holdings, and the filing of a Grayscale spot ETF. The community is actively discussing ZEC's privacy features, often positioning it as "the better Bitcoin" as it demonstrates relative strength and triggers short squeeze anticipation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


conggamezo789

ZO 789